Meningitis Diagnostic Testing Market Trends, 2017-2025

Meningitis Diagnostic Testing Market (Products - Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test; Industry - Hospitals, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Meningitis Diagnostic Testing Market: Outlook

Rapid innovations and upgradations in the healthcare and diagnostic technologies that allows for precise diagnostics in minimal time are positively influencing the demand within the global market.

The increase in the research and development activities intended for developing novel and accurate meningitis diagnosis solutions is also expected to bolster the demand dynamics within the global market over the forecast period of 2017 to 2025. However, lack of skilled technicians that can operate or handle advanced technological solutions and testing equipment may hamper the growth in the global market in coming years.

According to the corporate research report by the Transparency Market Research, the global meningitis diagnostic testing market is expected to expand at a steady growth rate of 3 % over the forecast period of 2017 to 2025.

The research report also predicts that the global market will surpass the evaluation of US$ 150.0 million by the end of the forecast period i.e. 2025. It also informs the readers that the global market was evaluated at US$ 105 million in the beginning of the forecast period i.e. 2016. Rising adoption of the solutions in the global market as well as easy availability of lateral flow assay are aiding in the expansion of the industry.

meningitis-diagnostic-testing-market.jpg

Rising Prevalence of Meningitis Fuels Demand in Meningitis Diagnostic Testing Market

The increasing demand for point of care services is likely to drive growth within the global market in coming years. The point of care services offer more precise results in less time as compared to the conventional meningitis diagnostic testing methods. Furthermore, rising prevalence of meningitis is anticipated to drive the growth within the global market in near future. On the other hand, presence of complex and stringent regulatory framework may hamper the development of the global market in coming years.

The types of products offered by the players and manufacturers in the global market include lateral flow assay, ELISA tests, latex agglutination tests, PCR tests, and culture tests, among others. The PCR test segment amounted for the highest industry share in terms of revenue in the global market in 2016. The PCR testing solutions offer a higher sensitivity rate of almost 97 % and provide results faster than the traditional testing methods. Moreover, another segment anticipated to expand at a stellar rate in coming years within the global meningitis diagnostic testing market is lateral flow assay. This trend can be attributed to the low cost, reliable, and rapid nature of the lateral flow assay tests.

End users for the products and solutions offered by the players and manufacturers in the global market are diagnostic centers and hospitals, among others. Among these, the hospital segment accounted for the largest share within the global meningitis diagnostic testing industry in the year 2016. This trend can be attributed to the rising number of international hospitals that feature technologically superior laboratory infrastructure.

Asia Pacific to Record Highest Growth Rate in Meningitis Diagnostic Testing Market in Near Future

Major regions and leading nations in the global market include Europe (including Germany, Italy, the United Kingdom, France, Spain, and rest of the Europe), Latin America (including Mexico, Brazil, and rest of the Latin America), North America (including the United States and Canada), Middle East and Africa (including Sub Saharan Africa, Middle East and North Africa, and rest of the Middle East and Africa), and Asia Pacific (including Japan, Australia, India, New Zealand, China, and rest of the Asia Pacific). Among these, the North America region dominated the global market in 2016. The regional market with second largest share in the global market in 2016 was Asia Pacific.

Rising patient awareness as well as the easy availability of rapid diagnostic testing equipment and kits are some of the major contributors for the expansion of the global meningitis diagnostic testing market in North America region. On the other hand, Asia Pacific global market is set to expand at the highest growth rate over the forecast period owing to massive population base in some of the major nations in the region, such as India and China. Furthermore, increase in the patient awareness as well as developing laboratory infrastructure in the region is also expected to bolster the growth of Asia Pacific region in the global market in near future.

Players in Meningitis Diagnostic Testing Market Engaged in Acquisitions and Collaborations

Few of the most notable players and manufacturers operational within the global market are Fast Track Diagnostics Ltd. (FTD), Bio-Rad Laboratories, Inc., BioFire Diagnostics, Luminex Corporation, Qnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers, IMMY, Nanosphere, Seegene Inc., and ELI Tech Group, among others. Major players and manufacturers in the global meningitis diagnostic testing market are focused on expanding their geographical presence as well as on diversifying their product portfolios by providing their conusmers with technologically advanced meningitis diagnostic testing solutions.

The research report also predicts that the global meningitis diagnostic testing market will expand at a stellar pace owing to the increasing demand for technologically superior meningitis diagnostic testing kits. This trend is anticipated to further intensify the competition within the global market. Players and manufacturers in the global market are engaged in corporate growth strategies such as strategic collaborations as well as acquisitions in order to capture a larger consumer base.

The global meningitis diagnostic testing market is segmented as follows:

Product

  • Latex Agglutination Tests
  • Lateral Flow Assay
  • PCR Assay
  • ELISA Tests
  • Culture Test
  • Others

End User

  • Hospital
  • Diagnostic Centers
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • Middle East & North Africa
    • Sub-Saharan Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of meningitis diagnostic testing market?

The market will surpass the evaluation of US$ 150.0 million by the end of 2025

What is the anticipated CAGR of the meningitis diagnostic testing industry in the forecast period?

The market is projected to register CAGR of over 3.0% from 2017 to 2025

What are the key driving factors for the growth of the meningitis diagnostic testing business?

The market is driven by increasing demand for point of care services and rising prevalence of meningitis

Which is the rising prominent meningitis diagnostic testing segment in the market?

The PCR Assay segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025

Who are the key meningitis diagnostic testing players?

Key players in the global market include Fast Track Diagnostics Ltd. (FTD), Bio-Rad Laboratories, Inc., BioFire Diagnostics, Luminex Corporation, Qnostics, Abbott Laboratories

    1. Preface 
         1.1. Report Scope and Market Segmentation 
         1.2. Research Highlights

    2. Assumptions and Research Methodology 
         2.1. Assumptions
         2.2. Acronyms Used
         2.3. Research Methodology

    3. Executive Summary
         3.1. Global Meningitis Diagnostic Testing Market Snapshot

    4. Market Overview
         4.1. Product Overview
         4.2. Key Industry Events 
         4.3. Global Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, 2015-2025 
         4.4. Market Opportunity Map
         4.5. Porter’s Analysis 
         4.6. Global Meningitis Diagnostic Testing Market Outlook

    5. Market Dynamics
         5.1. Drivers and Restraints Snapshot Analysis
         5.2. Drivers
         5.3. Restraints
         5.4. Trends
         5.1. Key Success factor for Top Players
         5.2. Key Mergers and Acquisitions-In vitro Diagnostics (IVD) Industry 
         5.3. Regulatory Scenario

    6. Global Meningitis Diagnostic Testing Market Analysis, by Product
         6.1. Introduction
         6.2. Key Findings
         6.3. Global Meningitis Diagnostic Testing Market Value Share, by Product 
         6.4. Global Meningitis Diagnostic Testing Market Forecast, by Product
                6.4.1. Latex Agglutination Tests 
                6.4.2. Lateral Flow Assay
                6.4.3. PCR Assay
                6.4.4. ELISA Tests 
                6.4.5. Culture Test
                6.4.6. Others
         6.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product

    7. Global Meningitis Diagnostics Testing Market Analysis, by End User
         7.1. Introduction
         7.2. Key Findings
         7.3. Global Meningitis Diagnostic Testing Market Value Share Analysis, by End User
         7.4. Global Meningitis Diagnostic Testing Market Forecast, by End User
                7.4.1. Hospital
                7.4.2. Diagnostic Center
                7.4.3. Others
         7.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by End User

    8. Global Meningitis Diagnostic Testing Market Analysis, by Region
         8.1. Global Market Scenario by Country
         8.2. Global Meningitis Diagnostic Testing Market Value Share Analysis, by Region
         8.3. Global Meningitis Diagnostic Testing Forecast, by Region
                8.3.1. North America
                8.3.2. Europe
                8.3.3. Asia Pacific
                8.3.4. Latin America
                8.3.5. Middle East & Africa
         8.4. Global Meningitis Diagnostic Testing Attractiveness Analysis By Region

    9. North America Meningitis Diagnostic Testing Market Analysis
         9.1. Key Findings
         9.2. Market Overview
         9.3. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
         9.4. North America Meningitis Diagnostic Testing Market Forecast, by Country
         9.5. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
         9.6. North America Meningitis Diagnostic Testing Market Forecast, by Product
                9.6.1. Latex Agglutination Tests 
                9.6.2. Lateral Flow Assay
                9.6.3. PCR Assay
                9.6.4. ELISA Tests 
                9.6.5. Culture Test
                9.6.6. Others
         9.7. North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
         9.8. North America Meningitis Diagnostic Testing Market Forecast, by End-user
                9.8.1. Hospital
                9.8.2. Diagnostic Center
                9.8.3. Others
         9.9. North America Meningitis Diagnostic Testing Market Attractiveness Analysis

    10. Europe Meningitis Diagnostic Testing Market Analysis
         10.1. Key Findings
         10.2. Market Overview
         10.3. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country
         10.4. Europe Meningitis Diagnostic Testing Market Forecast, by Country
                10.4.1. U.S.
                10.4.2. Canada
         10.5. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product
         10.6. Europe Meningitis Diagnostic Testing Market Forecast, by Product
                10.6.1. Latex Agglutination Tests 
                10.6.2. Lateral Flow Assay
                10.6.3. PCR Assay
                10.6.4. ELISA Tests 
                10.6.5. Culture Test
                10.6.6. Others
         10.7. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
         10.8. Europe Meningitis Diagnostic Testing Market Forecast, by End-user
                10.8.1. Hospital
                10.8.2. Diagnostic Center
                10.8.3. Others
         10.9. Europe Meningitis Diagnostic Testing Market Attractiveness Analysis

    11. Asia Pacific Meningitis Diagnostic Testing Market Analysis
         11.1. Key Findings
         11.2. Market Overview
         11.3. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country
         11.4. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Country
                11.4.1. U.K.
                11.4.2. Germany
                11.4.3. France
                11.4.4. Italy
                11.4.5. Spain
                11.4.6. Rest of Europe
         11.5. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product
         11.6. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Product
                11.6.1. Latex Agglutination Tests 
                11.6.2. Lateral Flow Assay
                11.6.3. PCR Assay
                11.6.4. ELISA Tests 
                11.6.5. Culture Test
                11.6.6. Others
         11.7. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
         11.8. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by End-user
                11.8.1. Hospital
                11.8.2. Diagnostic Center
                11.8.3. Others
         11.9. Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis

    12. Latin America Meningitis Diagnostic Testing Market Analysis
         12.1. Key Findings
         12.2. Market Overview
         12.3. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
                12.3.1. Brazil
                12.3.2. Mexico
                12.3.3. Rest of Latin America
         12.4. Latin America Meningitis Diagnostic Testing Market Forecast, by Country
         12.5. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
         12.6. Latin America Meningitis Diagnostic Testing Market Forecast, by Product
                12.6.1. Latex Agglutination Tests 
                12.6.2. Lateral Flow Assay
                12.6.3. PCR Assay
                12.6.4. ELISA Tests 
                12.6.5. Culture Test
                12.6.6. Others
         12.7. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
         12.8. Latin America Meningitis Diagnostic Testing Market Forecast, by End-user
                12.8.1. Hospital
                12.8.2. Diagnostic Center
                12.8.3. Others
         12.9. Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis

    13. Middle East & Africa Meningitis Diagnostic Testing Market Analysis
         13.1. Key Findings
         13.2. Market Overview
         13.3. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country
                13.3.1. Middle East & North Africa
                13.3.2. Sub-Saharan Africa
                13.3.3. Rest of Africa
         13.4. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Country
         13.5. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product
         13.6. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Product
                13.6.1. Latex Agglutination Tests 
                13.6.2. Lateral Flow Assay
                13.6.3. PCR Assay
                13.6.4. ELISA Tests 
                13.6.5. Culture Test
                13.6.6. Others
         13.7. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
         13.8. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by End-user
                13.8.1. Hospital
                13.8.2. Diagnostic Center
                13.8.3. Others
         13.9. Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis

    14. Competition Landscape
         14.1. Meningitis Diagnostic Testing Market Share Analysis By Company, 2015
         14.2. Competition Matrix
         14.3. Company Profiles
                14.3.1. Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers 
                          14.3.1.1. Company Details
                          14.3.1.2. Business Overview
                          14.3.1.3. Financial Overview
                          14.3.1.4. Strategic Overview
                          14.3.1.5. SWOT Analysis
                14.3.2. Thermo Fisher Scientific, Inc.
                          14.3.2.1. Company Details
                          14.3.2.2. Business Overview
                          14.3.2.3. Financial Overview
                          14.3.2.4. Strategic Overview
                          14.3.2.5. SWOT Analysis
                14.3.3. Abbott Laboratories.
                          14.3.3.1. Company Details
                          14.3.3.2. Business Overview
                          14.3.3.3. Financial Overview
                          14.3.3.4. Strategic Overview
                          14.3.3.5. SWOT Analysis
                14.3.4. Bio-Rad Laboratories, Inc.
                          14.3.4.1. Company Details
                          14.3.4.2. Business Overview
                          14.3.4.3. Financial Overview
                          14.3.4.4. Strategic Overview
                          14.3.4.5. SWOT Analysis
                14.3.5. Seegene Inc.
                          14.3.5.1. Company Details
                          14.3.5.2. Business Overview
                          14.3.5.3. Financial Overview
                          14.3.5.4. Strategic Overview
                          14.3.5.5. SWOT Analysis
                14.3.6. DiagCor Bioscience Inc. Ltd
                          14.3.6.1. Company Details
                          14.3.6.2. Business Overview
                          14.3.6.3. Financial Overview
                          14.3.6.4. Strategic Overview
                          14.3.6.5. SWOT Analysis
                14.3.7. BioFire Diagnostics (bioMerieux)
                          14.3.7.1. Company Details
                          14.3.7.2. Business Overview
                          14.3.7.3. Financial Overview
                          14.3.7.4. Strategic Overview
                          14.3.7.5. SWOT Analysis
                14.3.8. IMMY
                          14.3.8.1. Company Details
                          14.3.8.2. Business Overview
                          14.3.8.3. Financial Overview
                          14.3.8.4. Strategic Overview
                          14.3.8.5. SWOT Analysis
                14.3.9. Nanosphere (Luminex Corporation).
                          14.3.9.1. Company Details
                          14.3.9.2. Business Overview
                          14.3.9.3. Financial Overview
                          14.3.9.4. Strategic Overview
                          14.3.9.5. SWOT Analysis

    List of Tables

    TABLE 1 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by Product, 2015–2025
    TABLE 2 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 3 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
    TABLE 4 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
    TABLE 5 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
    TABLE 6 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 7 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country /Sub-region, 2015–2025
    TABLE 8 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
    TABLE 9 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 10 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    TABLE 11 Table 11: Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
    TABLE 12 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 13 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    TABLE 14 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
    TABLE 15 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 16 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    TABLE 17 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
    TABLE 18 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 19 Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers Business Overview
    TABLE 20 Thermo Fisher Scientific, Inc. Business Overview
    TABLE 21 Abbott Laboratories Business Overview
    TABLE 22 Bio-Rad Laboratories, Inc. Business Overview
    TABLE 23 Seegene Inc. Business Overview
    TABLE 24 DiagCor Bioscience Inc. Ltd Business Overview
    TABLE 25 BioFire Diagnostics (bioMérieux) Business Overview
    TABLE 26 IMMY Business Overview
    TABLE 27 Nanosphere (Luminex Corporation) Business Overview

    List of Figures

    FIG. 1 Global Meningitis Diagnostics Testing Market  Share (US$ Mn), by Product, 2016
    FIG. 2 Global Meningitis Diagnostics Testing Market Share (%), by End User, 2016
    FIG. 3 Revenue Share, by product, 2016
    FIG. 4 Revenue Share, by end user, 2016
    FIG. 5 Global Meningitis Diagnostic Testing Market  Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    FIG. 6 Market Value Share, by Product (2016)
    FIG. 7 Market Value Share, by Distribution Channel (2016)
    FIG. 8 Market Value Share, by Region (2016) 
    FIG. 9 Global Meningitis Diagnostic Testing Market Value Share, by Product, 2016 and 2025
    FIG. 10 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Latex Agglutination Test, 2015–2025
    FIG. 11 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lateral Flow Assay, 2015–2025
    FIG. 12 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCR Assay, 2015–2025
    FIG. 13 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by ELISA Test, 2015–2025
    FIG. 14 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Culture Test, 2015–2025
    FIG. 15 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
    FIG. 16 Global Meningitis Diagnostic Testing Market Attractiveness, by Product
    FIG. 17 Global Meningitis Diagnostic Testing Market Value Share, by End-user, 2016 and 2025
    FIG. 18 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
    FIG. 19 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2015–2025
    FIG. 20 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2015–2025
    FIG. 21 Global Meningitis Diagnostic Testing Market Attractiveness, by End-user
    FIG. 22 Global Meningitis Diagnostic Testing Market Value Share, by Region, 2016 and 2025
    FIG. 23 Global Meningitis Diagnostic Testing Attractiveness Analysis, by Region, 2017–2025
    FIG. 24 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    FIG. 25 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country, 2017–2025
    FIG. 26 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country, 2016 and 2025
    FIG. 27 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
    FIG. 28 North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 29 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
    FIG. 30 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 31 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    FIG. 32 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
    FIG. 33 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    FIG. 34 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
    FIG. 35 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 36 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
    FIG. 37 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 38 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    FIG. 39 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
    FIG. 40 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    FIG. 41 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
    FIG. 42 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 43 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
    FIG. 44 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 45 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    FIG. 46 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
    FIG. 47 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    FIG. 48 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
    FIG. 49 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 50 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
    FIG. 51 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 52 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    FIG. 53 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
    FIG. 54 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    FIG. 55 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
    FIG. 56 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 57 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
    FIG. 58 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 59 Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
    FIG. 60 Thermo Fisher Scientific, Inc. Research & Development Expenses (US$ Mn), 2015–2016
    FIG. 61 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2016
    FIG. 62 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2016
    FIG. 63 Abbott Laboratories Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
    FIG. 64 Abbott Laboratories Research & Development Expenses (US$ Bn), 2015–2016
    FIG. 65 Abbott Laboratories Breakdown of Net Sales, by Region, 2016
    FIG. 66 Abbott Laboratories Breakdown of Net Sales, by Segment, 2016
    FIG. 67 Bio-Rad Laboratories, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
    FIG. 68 Bio-Rad Laboratories, Inc. Research & Development Expenses (US$ Mn), 2015–2016
    FIG. 69 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Geography, 2016
    FIG. 70 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Segment, 2016
    FIG. 71 Seegene Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
    FIG. 72 Seegene Inc. Research & Development Expenses (US$ Mn), 2014–2016
    FIG. 73 Seegene Inc. Breakdown of Net Sales, by Region, 2016
    FIG. 74 Seegene Inc. Breakdown of Net Sales, by Business Segment, 2016
    FIG. 75 Nanosphere Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
    FIG. 76 Nanosphere  Research & Development Expenses (US$ Mn), 2014–2016
    FIG. 77 Nanosphere Breakdown of Net Sales, by Business Segment, 2016

Copyright © Transparency Market Research, Inc. All Rights reserved